23-09-2016

GGGNNNIIIPPPSSSTTT BBBUUULLLLLLEEETTTIIINNN 222000111666 23rd September, 2016 Volume No.: 59 Issue No.: 02

Vision To develop responsible citizens who would be professionally equipped to ‘think globally and act locally’ and become reformers of society to meet the challenges of future.

Mission To impart high quality pharmaceutical science, technology and management education to the budding professionals and provide the ambience needed for developing requisite skills to make a mark of excellence in Education, Research, Business , Industry and achieve highest personal standards.

Contents • Message from PRINCIPAL• Editorial board• Historical article• News Update• Knowledge based Article• Disease Related Breaking News• Upcoming Events• Drugs Update• Campus News• Student’s Section• Editor’s Note

• Archive

GNIPST Photo Gallery For your comments/contribution

OR For Back-Issues, mailto:gnipstbulletin@gmail.com

GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

W e bs i t e : ht t p: / / gni ps t. a c. i n

23-09-2016

MESSAGE FROM PRINCIPAL

"It can happen. It does happen. But it can't happen if you quit." Lauren Dane.

‘We are what we repeatedly do. Excellence then is not an act, but a habit.’ Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the last year’s editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academic excellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners are supported in maximizing their potential and talents. Education needs to focus on personalized learning and instruction, while promoting an education system that is impartial, universally accessible, and meeting the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order to achieve their aims. We are all very proud of you, our students, and your accomplishments and look forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looking forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in this direction and fruits of these efforts will be received by our students in the near future. Our Teachers are committed and dedicated for the development of the institution by imparting their knowledge and play the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1

23-09-2016

EDITORIAL BOARD CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM ASSOCIATE EDITOR MR. DIPANJAN

MANDAL

HISTORICAL ARTICLEFranz Boas 1858-1942

Widely considered to be one of the greatest and most influential anthropologists ever, Franz Boas was a German-American scientist, who is also known as the “Father of Modern Anthropology”. He was the first person to implement the scientific method into the study of human cultures and societies. Early Life and Education: Born in Minden, Westphalia, Franz Boas showed an early interest in both nature and natural sciences. He studied at the universities of Heidelberg, Bonn, and Kiel, and finally got his Ph.D. in physics with a minor in geography from the University of Kiel in 1881. Boas worked in Baffinland, Canada, from 1883 to 1884, while from 1885 to 1886; he conducted field research in several museums on the North Pacific Coast of North America. He was also an important part of a project involving the cultures of Native Americans which lasted almost one year. Contributions and Achievements: Franz Boas was the most important figure in 20th century North American anthropology. He laid down the four-field structure of the discipline around cultural, physical, linguistic and archaeological disciplines pertaining to the American Indian. He also trained many professional anthropologists. Boas made memorable contributions to the changes in immigrant head form undercut eugenics arguments and lessened the significance of anthropometric measures of race.

Click here to go at the top

2

23-09-2016

The archaeological works of Franz Boas were almost cursory. While studying culture, his theoretical contributions dealt with the critique of evolution. He destroyed the rationalist theories of human nature. His historical particularism, his insistency on stringent ethnographic method, and his stress on “the native point of view” were pivotal to the development of modern anthroplogy. Later Life and Death: Franz Boas oversaw the Columbia Anthropology Department for more than four decades. Boas died on 21 December, 1942. He was 84 years old.

NEWS UPDATE Ancient remedy becomes novel approach to

treating clostridium difficile infection: (16th September, 2016) The epidemiology of Clostridium difficile (C. diff) infection, clinical presentation of infection, diagnosis and various therapies including fecal microbiota transplant have been the focus of recent research, all laid out in a new report.

Scientists spot genes that make some sarcomas less aggressive: (21st September, 2016) A set of genes they say make sarcoma cells less aggressive has been discovered by researchers. They hope to turn the discovery into new therapeutic approaches to fight metastatic cancers.

Blood biomarkers in drug-resistant cancer tumor cells identified: (21st September, 2016) While searching for a non-invasive way to detect prostate cancer cells circulating in blood, researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.

Click here to go at the top

3

23-09-2016

Immune and targeted therapies with radiation therapy improves outcomes for melanoma brain metastases patients, say researchers: (21st September, 2016) Researchers have sought to determine if patients with melanoma brain metastases treated with immune and targeted therapies had improved outcomes over patients treated with conventional chemotherapy. They retrospectively analyzed data from 96 patients with melanoma brain metastases who were treated with stereotactic radiation therapy within 3 months of different targeted therapies (anti–PD-1 therapy, anti–CTLA-4 therapy, BRAF inhibitor plus a MEK inhibitor, or a BRAF inhibitor alone) or conventional chemotherapy.

New genetic tool created to identify people at risk of coronary heart disease: (21st September, 2016) A new genetic risk score that could help to identify individuals at risk of coronary heart disease (CHD) much earlier and potentially improve its prevention has been developed by scientists.

Care home dementia study finds failure to reduce antipsychotic prescribing: (20th September, 2016) There has been no sustained reduction in the prescription of antipsychotics to UK dementia patients, despite government guidance, according to a report.

Researchers find a potential signature of cognitive function in people living with HIV: (20th September, 2016) A unique epigenetic footprint has been found in specific types of immune cells from blood that can identify individuals with HIV

Click here to go at the top

4

23-09-2016

that have a range of impairments in cognitive function. Reliable biomarkers such as that identified by the researchers offer insight into how HIV-associated cognitive impairment develops but also promises improved diagnostic testing and improved treatment decisions.

How to power up graphene implants without frying cells: (23rd September, 2016) In the future, our health may be monitored and maintained by tiny sensors and drug dispensers, deployed within the body and made from graphene -- one of the strongest, lightest materials in the world. Graphene is composed of a single sheet of carbon atoms, linked together like razor-thin chicken wire, and its properties may be tuned in countless ways, making it a versatile material for tiny, next-generation implants. For detail mail to editor

KNOWLEDGE BASED ARTICLE Expanded indications for Ilaris for three rare

diseases There are three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients:

• Tumor Necrosis Factor Receptor Associated PeriodicSyndrome (TRAPS);

• Hyperimmunoglobulin D Syndrome (HIDS)/MevalonateKinase Deficiency (MKD); and

• Familial Mediterranean Fever (FMF).All three syndromes are hereditary diseases that are characterized by periodic attacks of fever and inflammation, as well as severe muscle pain. There are no previously approved therapies for TRAPS or HIDS/MKD. “For the first time, patients with TRAPS and HIDS/MKD, two painful and life altering diseases, have access to a treatment that

Click here to go at the top

5

23-09-2016

may help improve their quality of life,” said Badrul Chowdhury, M.D., Ph.D, director of the Division of Pulmonary, Allergy and Rheumatology Products in FDA’s Center for Drug Evaluation and Research. Ilaris was previously approved for another periodic fever syndrome called Cryopyrin-Associated Periodic Syndromes (CAPS) and for active systemic juvenile idiopathic arthritis. Health care professionals should review the prescribing information in the labeling for detailed information about the approved uses. Approvals for the new indications were based on clinical studies, including safety, efficacy and pharmacokinetic data. The most common adverse reactions for these indications are injection site reactions and being more susceptible to catching colds. Ilaris can cause serious side effects, including increased risk of serious infections. Ilaris can lower the immune system’s ability to fight infections. Other serious side effects include decreased ability to fight infections (immunosuppression) and allergic reactions. Patients experiencing any symptoms of an allergic reaction should call their healthcare provider, including: rash, itching and hives, difficulty breathing or swallowing, and dizziness or feeling faint. Patients should not get live vaccines if receiving Ilaris. Patients should not receive Ilaris if they are allergic to canakinumab or any of the ingredients in Ilaris. Ilaris is manufactured and distributed by Novartis Pharmaceuticals Corporation, of East Hanover, New Jersey. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency is also responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Jeenatara Begum Assistant Professor

GNIPST

Click here to go at the top

6

23-09-2016

DISEASE RELATED BREAKING NEWS Middle East respiratory syndrome coronavirus

(MERS-CoV) – Austria: (20th September, 2016) On 8 September 2016 the National IHR Focal Point for Austria notified WHO of a laboratory confirmed case of Middle-East respiratory syndrome coronavirus (MERS-CoV) infection. This is the second case of MERS-CoV in Austria. (The first MERS-CoV case in Austria was notified on 30 September 2014). Read more

UPCOMING EVENTS IPGA sponsored National Seminar on “Current status of

Regulatory Affairs for Pharmaceuticals” wll be held on 24th to 25th September, 2016 at B.N.College of Pharmacy, Bhopal Nobles University, Udaipur.

DRUGS UPDATES FDA Approves Amjevita (adalimumab-atto), a

Biosimilar to Humira: (23rd September, 2016) The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. Read more

CAMPUS NEWS NBA visit:

The experts of National Board of Accreditation or NBA will be going to visit GNIPST on 24th September and 25th September, 2016.

Click here to go at the top

7

23-09-2016

Freshers welcome programme: On 12th September GNIPST organized the Freshers welcome programme Kulrav 2k16.

GNIPST Football Match 2016: On 31st August and 1st September GNIPST sports club organized a football match. The winner of the football match was B.Pharm 3rd year.

Recent Trends in Pharmaceutical Research: A Science Awareness Programme comprising of seminar on “Recent Trends in Pharmaceutical Research” was organized by GNIPST in collaboration with National Academy of Science India (NASI) on 30th august, 2016 from 2 pm to 4.30 pm at GNIPST auditorium. Plantation programme was also organized by Eco club. Dr. Hemanta Kumar Majumder, gave his valuable lecture on “Modern Biology & its Evolution” and Dr. Pijush K Das delivered his lecture on “Site specific Drug Targeting –Magic Bullet approach”.

World Photography Day celebration: On 19th August 2016 GNIPST celebrated World Photography Day at Dakhineswar.

Friendly Football Match: On 15th August 2016 GNIPST organised a friendly football match with Alumni members.

Farewell 2016: On 25th May 2016 GNIPST celebrated the farewell programme for the final year students. Best of luck to all final year students for their future life.

ALUMNI MEMBERS 2016: Congratulations to new Alumni Members of GNIPST.

Click here to go at the top

8

23-09-2016

Placement Record 2016: SL NO

COMPANY NAME NUMBER OF STUDENT

APPEARED/APPLIED

NUMBER OF STUDENT

SELECTED

JOB PROFILE

1 DR. LAL PATH LAB 64 7 Sales, Marketing and office assistant

2 APOLLO PHARMACY

36 25 Hospital and retail chain pharmacist

3 ABBOTT INDIA 74 03 Sales and Marketing

4 HETERO DRUGS 18 18 (Waiting for final

interview)

Production, QC and QA

5 ERIS LIFE SCIENCES 01 01 (Joined) Sales and Marketing

6 JUPITER PHARMACEUTICALS

05 01 (Joined) Production, QC and QA

7 GOVT PHARMACIST 4 4 (Joined) Hospital Pharmacist

8 ALCHEMIST EYE HOSPITAL

2 2 (Waiting for final

interview)

Hospital Pharmacist

9 OPTIVAL HEALTH SOLUTIONS PVT. LTD. (MEDPLUS)

21 21 Community Pharmacist

10 NESTLE INDIA LTD 08 02 Nutrition Officer Trainee

11 LUPIN 01 01 Sales and Marketing

12 GSK PHARMACEUTICAL

LTD

05 02 (1 of them already joined)

Sales and Marketing

13 OAK PHARMACEUTICAL

06 02 (Joined) Sales and Marketing

Click here to go at the top

9

23-09-2016

IPA Bengal Pharma & Healthcare trust scholarship 2016: Congratulations to Rudradip Das, student of B.Pharm 3rd year has been awarded IPA Bengal Pharma & Healthcare trust scholarship 2016.

Accreditation by NAAC: SL. NO.

NAME OF THE INSTITUTE

STATE CGPA(out of scale 4)

GRADE

01 Guru Nanak Institute of Pharmaceutical Science And Technology, Kolkata-700114

West Bengal

2.70 B

GPAT 2016 Result: The following B.Pharm. final year students have qualified, GPAT-2016. We congratulate them all. Aishika Datta Mainak Chatterjee Indira Saha Priyanka De Aheli Mukherjee Soumya Guha Debanjana Das Debalina Datta Evana Patra Himadrija Chatterjee

IRIS 2016: GNIPST organized colllege fest ‘IRIS 2016’ from 11th to 13th March, 2016. Result of different events: Intracollege Quiz competition: 1st: Arani Roy and Dipayan Nath

Click here to go at the top

10

23-09-2016

2nd: Bhaskar Singha and Pratik Nandi Intracollege Painting competition: 1st: Swagata Paul 2nd: Aviraj Pathak 3rd: Dippyoman Guha Group Dance Competition: Karma Group Intercollege Solo Dance Competition: 1st : Monodipa Ghosh 2nd: Aditya Paul (NIT) Antaksari Competition: 1st: Sunanda and Aparupa 2nd: Meghna and Joyita 3rd: Arpita and Pami Intercollege Solo Singing Competition: 1st: Arpita Sarkar 2nd: Arvind Raj (Sudhir Chandra College) 3rd: Priyam Mondal (Supreme College) Intercollege Band Competition: 1st: D Errors 2nd: Mukti 3rd: GNIPST band Fashion: Best Male: Md. Nadeem Shah Best Female: Sweta Best Couple: Md. Nadeem Shah and Susmita Kar

Blood donation Camp 2016: On 4th March 2016 Social Service club and Alumni Association of GNIPST organized a Blood donation camp in association with Association of voluntary Blood Donars, West Bengal.

Click here to go at the top

11

23-09-2016

Reminiscence & 1st Alumni meet 2016: On 28th February 2016 GNIPST organized the Reunion programme “Reminiscence & 1st Alumni meet 2016”.

National Assessment and Accreditation Council (NAAC): A NAAC peer team completed a three-day inspection (17th February to 19th February, 2016) of GNIPST to evaluate its academic credibility and infrastructure on Friday.

Saraswati Puja 2016: On 13th February 2016 the students of GNIPST celebrated Saraswati Puja at GNIPST campus.

STUDENTS’ SECTION WHO CAN ANSWER FIRST????

Identify the Person

Answer of Previous Issue’s Qestion:

Irene Curie

Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students’ Section& answers of this Section at gnipstbulletin@gmail.com

EDITOR’S NOTE It is a great pleasure for me to publish the 2nd issue of 59th Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN

Click here to go at the top

12

23-09-2016

are able to avail the bulletin through facebook account ‘GNIPST bulletin’ I am very much thankful to all the GNIPST members and readers who are giving their valuable comments, encouragements and supports. I am also thankful to Dr. Abhijit Sengupta, Director of GNIPST for his valuable advice and encouragement. Special thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya Bhattacharya for their kind co-operation and technical supports. Thank you Mr. Soumya Bhattacharya for the questionnaires of the student section. An important part of the improvement of the bulletin is the contribution of the readers. You are invited to send in your write ups, notes, critiques or any kind of contribution for the forthcoming special and regular issue.

ARCHIVE OTHERS: AICTE has sanctioned a release of grant under ResearchPromotion Scheme (RPS) during the financial year 2012-13to GNIPST as per the details below: a. Beneficiary Institution: Guru Nanak Institution of PharmaceuticalScience & Technology.

b. Principal Investigator: Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d. Approved duration: 3 yearse. Title of the project: Screening and identification of potential

medicinal plant of Purulia & Bankura districts of West Bengal with respect to diseases such as diabetes, rheumatism, Jaundice, hypertension and developing biotechnological tools for enhancing bioactive molecules in these plants.

Click here to go at the top

13

23-09-2016

Activity Clubs of GNIPST: Name of Club Member Faculty CULTURAL Ms. Priyanka Ray DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya ECO Ms. Sumana Roy LITERARY AND PAINTING Ms. Jeenatara Begum PHOTOGRAPHY Ms. Sanchari Bhattacharya and

Mr. Abir Koley SCIENCE AND INNOVATIVE MODELLING

Mr. Samrat Bose

SOCIAL SERVICES Dr. Asis Bala SPORTS Mr. Debabrata GhoshDastidar

Click here to go at the top

14